Medical Devices

Automated Industrial Robotics Inc. (“AIR” or the “Company”) today announced the acquisition of KAON Automation (“KAON”), an Ireland-based industrial automation company that delivers advanced automation solutions for leading manufacturing companies globally. In addition to strengthening AIR’s existing presence in Ireland, the transaction expands the Company’s presence in the medical and life sciences end markets and

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, announces the acquisition of Vivasure Medical Limited (Vivasure), a Galway, Ireland-based company pioneering next-generation technology for percutaneous vessel closure. The acquisition includes an upfront cash payment of €100 million, or approximately €52 million net of the

NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of the Early Development medical device testing business of Labcorp (NYSE: LH), a leading provider of innovative and comprehensive laboratory services. This strategic move underscores NAMSA’s commitment to advancing innovation and accelerating time-to-market

Sheridan Capital Partners (“Sheridan”) announces that its portfolio company, Currier Plastics (“Currier”), has completed the strategic acquisitions of medical contract manufacturing businesses Springboard Manufacturing (“Springboard”) and MOS Plastics (“MOS”). Springboard, based in Rancho Cordova, California, serves blue chip life sciences customers with contract manufacturing services, including custom-molded precision components, tooling and assembly. MOS is a